Maintenance Therapy after a Transplant for Multiple Myeloma

OncoAlert Session Round Up at #ASH24 in Multiple Myeloma: Advancing Minimal Residual Disease (MRD)Подробнее

Regional Myeloma Community WorkshopПодробнее

Maintenance Therapy for Multiple Myeloma: Key Strategies and InsightsПодробнее

Iberdomide Maintenance Therapy after ASCT in Myeloma | Tanye Wildes, MD | IMS 2024Подробнее

Multiple myelomaПодробнее

Answering Your Top Myeloma Questions: Maintenance Therapy, Imaging, Neuropathy, and MoreПодробнее

Dara + Len vs Len Alone as Maintenance Therapy -AURIGA | Ashraf Badros, MD | IMS 2024Подробнее

Advances in the treatment of transplant-eligible and ineligible multiple myelomaПодробнее

New Advances in the Care of Multiple MyelomaПодробнее

Real-world outcomes of tandem transplantation in patients with newly diagnosed multiple myelomaПодробнее

Updates on Treating Newly Diagnosed Multiple MyelomaПодробнее

Clinical Clips in Advanced Newly Diagnosed Multiple Myeloma: Updates from EHA 2024Подробнее

Oral proteasome inhibitor ixazomib feasible for maintenance therapy in multiple myelomaПодробнее

The effects of maintenance therapy on real-world outcomes for patients with NDMMПодробнее

Episode 2 - Integrating Quadruplet Regimens in Newly Diagnosed Multiple Myeloma: Patient Focused ...Подробнее

The Role of Maintenance Therapy in Today's Myeloma: Has Anything Changed?Подробнее

Evolving Paradigms in Myeloma MaintenanceПодробнее

Integrating Quadruplet Regimens in Newly Diagnosed Multiple MyelomaПодробнее

Predictors of unsustained MRD negativity in transplant-eligible patients with multiple myelomaПодробнее